Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2006
07/20/2006US20060160759 Influenza therapeutic
07/20/2006US20060160758 Antisense modulation of CD40 ligand expression
07/20/2006US20060160757 RNA interference mediated inhibition hairless of (HR) gene expression using short interfering nucleic acid (siNA)
07/20/2006US20060160738 Stem cell factor-like proteins and uses thereof
07/20/2006US20060160732 Compositions and methods for inhibiting cell senescence and hyperproliferative disorders
07/20/2006US20060160731 Peptide nucleic acids
07/20/2006US20060160700 Nadh-dependent cytochrome b5 reductase as target for herbicides
07/20/2006US20060160202 Bacterial artificial chromosome vector for use in the propagation and transfer of genetic material; equine herpesvirus (EHV)
07/20/2006US20060160193 Suitable for use in the manufacture of microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica)
07/20/2006US20060160187 Combinatorial interleukin-2 muteins
07/20/2006US20060160186 Nucleic acid underexpressed in stomach tumor and lung tumor
07/20/2006US20060160182 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
07/20/2006US20060160181 Fibroblast Growth Factor-23 molecules and uses thereof
07/20/2006US20060160179 Filamentous fungal host cells to produce glycans without mannosylphosphate residues, therapy
07/20/2006US20060160178 Methods of generating antibody diversity in vitro
07/20/2006US20060160177 Peptide extended glycosylated polypeptides
07/20/2006US20060160176 High throughput cell-based functional assays and using cells, e.g., HEK-293 cells that express a G protein such as G alpha 15, G alpha 16 or gustducin.
07/20/2006US20060160175 Compositions of orthogonal leucyl-trna and aminoacyl-trna synthetase pairs and uses thereof
07/20/2006US20060160174 Modified l49-sfv exhibiting increased stability and methods of use thereof
07/20/2006US20060160173 Compared with a homoserine transsuccinylase wild-type enzyme, exhibits a reduced sensitivity toward L-methionine or S-Adenosylmethionine, with the wild-type enzyme possessing an amino acid sequence which comprises a constituent sequence TyrGlnXaaThrPro, with the Thr at position 297 onward being replaced
07/20/2006US20060160172 Sqs gene
07/20/2006US20060160158 Target and method for inhibition of bacterial rna polymerase
07/20/2006US20060160157 Method, compositions and classification for tumor diagnostics and treatment
07/20/2006US20060160152 Protein for use in the treatment of inflammation, allergies, asthma and leukemias
07/20/2006US20060160147 Recombinant cell line
07/20/2006US20060160146 Method of screening compound affecting amyloid beta production
07/20/2006US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
07/20/2006US20060160140 Human nuclear receptor protein nNR7-1
07/20/2006US20060160139 Rhesus BCRP and antibodies thereto
07/20/2006US20060160133 Glucose-transport related genes, polypeptides, and methods of use thereof
07/20/2006US20060160128 Novel adenosine deaminase homolog
07/20/2006US20060160126 90 human secreted proteins
07/20/2006US20060160123 For increasing stability of short interfering RNA molecule when in contact with biological sample, and reducing off-target effects/interferon responsiveness; ribonuclease stability
07/20/2006US20060160108 Populations of reporter sequences and methods of their use
07/20/2006US20060160106 Using peptide nucleic acid probes to detect chromosome aberrations in eukaryotic cells
07/20/2006US20060160105 determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at said locus which indicates the presence or absence of a chromosomal abnormality; non-invasive method for fetal DNA testing
07/20/2006US20060160103 Mammalian neuralized family transcriptional regulators and uses
07/20/2006US20060160099 Substrate preparation process
07/20/2006US20060160094 Determining appropriate treatment of a neoplasia by comparing a p53 gene or transcript in a human tumor sample to a wild-type p53 gene or a transcript having a size of 2.8 kb in normal human tissue and identifying the differences
07/20/2006US20060160093 Introduction of structural affinity handles as a tool in selective nucleic acid separations
07/20/2006US20060160092 useful for evaluating actin cytoskeleton-controlling agents; as a functional marker of the intercalate disc for heart diseases, such as myocardial infarction and myocarditis, due to its extremely high expression at the intercalate disc of cardiac muscle cells
07/20/2006US20060160091 Polynucleotides encoding a class II cytokine receptor
07/20/2006US20060160090 Composition splice variants and methods relating to cancer specific genes and proteins
07/20/2006US20060160086 Method for continuous detection of an analyte, trifunctional detecting reagent used and detecting device
07/20/2006US20060160085 Novel buffer formulations for isolating purifying and recovering long-chain and short-chain nucleic acids
07/20/2006US20060160082 Novel genes and proteins encoded thereby
07/20/2006US20060160081 Labelled nucleotides
07/20/2006US20060160075 nucleotides having a removable labels, used in polynucleotide sequencing
07/20/2006US20060160074 Pharmacogenetic DME detection assay methods and kits
07/20/2006US20060160072 using modified vaccinia topoisomerase enzyme containing an affinity tag to facilitate purification of protein-DNA complexes away from unbound DNA; ligating duplex DNAs; cloning DNA by introducing into a cell ligated duplex DNA
07/20/2006US20060160069 Methods and compositions for the diagnosis of cancer
07/20/2006US20060160067 GBV-B polynucleotide coding a virus having domain III of the 5' neurotrophin region from a hepatitis C virus 5' NTR, and at least part of a structural or non-structural protein coding region of HCV; viral expression construct; infectious GBV-B molecular clone
07/20/2006US20060159710 Pertussis toxin gene:cloning and expression of protective antigen
07/20/2006US20060159709 Recombinant high molecular weight major outer membrane protein of moraxella
07/20/2006US20060159707 Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
07/20/2006US20060159704 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents
07/20/2006US20060159697 Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
07/20/2006US20060159691 Ptprk immunogenic peptide
07/20/2006US20060159685 Of given sequence; immunomodulators; prophylaxis or treatments for cancers
07/20/2006US20060159659 RNA picornavirus; selectively kills some types of tumors; making new oncolytic virus derivatives and of altering viruses to have tumor-specific tropisms
07/20/2006US20060159654 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE
07/20/2006DE102005001191A1 Vorrichtung und Verfahren zur Fraktionierung von Mono- und/oder Oligosaccharid-Strukturen Device and method for the fractionation of the mono- and / or oligosaccharide structures
07/20/2006CA2594318A1 Irta-2 antibodies and their uses
07/20/2006CA2593779A1 Li-key/antigenic epitope hybrid peptide vaccines
07/20/2006CA2593583A1 Deprotection and purification of oligonucleotides and their derivatives
07/20/2006CA2562224A1 Nucleoside derivatives for treating hepatitis c virus infection
07/19/2006EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad)
07/19/2006EP1680657A2 Dmbt1 as a clinical marker and uses thereof
07/19/2006EP1680507A2 Bacterial expression of protease inhibitors and variants thereof
07/19/2006EP1680500A2 High temperature and alkaline stable catalase
07/19/2006EP1680448A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene
07/19/2006EP1680438A2 Amiphiphylic peptide-pna conjugates for the delivery of pna through the blood brain barrier
07/19/2006EP1680009A2 Compositions and methods for diagnosing and treating mental disorders
07/19/2006EP1679950A2 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene
07/19/2006EP1594955A4 An expression cassette and vector for transient or stable expression of exogenous molecules
07/19/2006EP1255815B1 Porcine reproductive and respiratory syndrome virus and methods of use
07/19/2006CN1806050A Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
07/19/2006CN1805757A Recombinant antibodies, and compositions and methods for making and using the same
07/19/2006CN1804038A VEGF expression-inhibiting siRNA and application thereof
07/19/2006CN1803824A Pig muscle enolase ENO3 and its use as genetic marker of pig production trait
07/19/2006CN1803823A SMAD4 gene expression-inhibiting SiRNA, its encoding sequence and application
07/19/2006CN1264981C Alfalfa Na+/H+ reverse transport protein gene and its clone and use
07/19/2006CN1264979C Yeast heat resistant related gene and its use
07/19/2006CN1264854C Method for DNA purification and purified DNA
07/18/2006US7078589 Isolated nematode regulated gene promoter and use thereof
07/18/2006US7078517 Using acid/alkali hydrolysis to recycle matrix comprising oligonucleotides immobilized via acid-amido bonding; reusable solid support for nucleotide sequences analysis
07/18/2006US7078516 Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
07/18/2006US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus
07/18/2006US7078513 plasmid is a viral or bacterial expression vector and is expressed in a prokaryotic or eukaryotic cell; gene therapy and immunotherapy; prenatal screening and diagnosis
07/18/2006US7078512 Encoding feline CD-86, -80, -28 and -152 receptors and ligands; enhancing and suppressing immune response in felines
07/18/2006US7078511 nucleic acid molecule encoding Hamster scavenger receptor BI (HaSR-BI) which has high affinity for low density lipoproteins (LDL) and acylated LDL, expressed in adipocytes; antilipemic, anticholesterol agents; receptor binding assay; drug screening
07/18/2006US7078510 Robust, inducible cardiac preferred expression system for transgenesis
07/18/2006US7078509 Lepidopteran-active Bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use
07/18/2006US7078508 Anticoagulant; Dna immobilized on substrate; binding to antibody
07/18/2006US7078507 Synthetic genes for malarial proteins and methods of use
07/18/2006US7078506 Canineil-4nucleic acid molecules and uses thereof
07/18/2006US7078505 Manufacture of arrays with varying deposition parameters
07/18/2006US7078504 Enzymes having dehalogenase activity and methods of use thereof
07/18/2006US7078503 Regulatory nucleotide sequences for use in controlling fertility, insect, pathogen, and herbicide resistance
07/18/2006US7078502 Nucleotide sequences for encoding of the lysR2-gene